Amedisys Balance Sheet Health
Financial Health criteria checks 4/6
Amedisys has a total shareholder equity of $1.1B and total debt of $374.7M, which brings its debt-to-equity ratio to 34.3%. Its total assets and total liabilities are $2.0B and $933.9M respectively. Amedisys's EBIT is $193.8M making its interest coverage ratio 7.4. It has cash and short-term investments of $78.1M.
Key information
34.3%
Debt to equity ratio
US$374.72m
Debt
Interest coverage ratio | 7.4x |
Cash | US$78.11m |
Equity | US$1.09b |
Total liabilities | US$933.90m |
Total assets | US$2.03b |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: A2ME34's short term assets ($467.2M) do not cover its short term liabilities ($468.1M).
Long Term Liabilities: A2ME34's short term assets ($467.2M) exceed its long term liabilities ($465.8M).
Debt to Equity History and Analysis
Debt Level: A2ME34's net debt to equity ratio (27.1%) is considered satisfactory.
Reducing Debt: A2ME34's debt to equity ratio has increased from 12.6% to 34.3% over the past 5 years.
Debt Coverage: A2ME34's debt is well covered by operating cash flow (31.4%).
Interest Coverage: A2ME34's interest payments on its debt are well covered by EBIT (7.4x coverage).